Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Mar 20;12(3):e228524.
doi: 10.1136/bcr-2018-228524.

Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus

Affiliations
Case Reports

Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus

Kalliopi Azariadis et al. BMJ Case Rep. .

Abstract

Glycogenic hepatopathy (GH) is a rare complication of poorly controlled type 1 diabetes mellitus (T1DM). We present a 19-year-old woman with T1DM and autoimmune thyroiditis who admitted to our department because of abrupt onset intermittent abdominal pain in the right upper quadrant accompanied by laboratory evidence of acute anicteric hepatitis. Physical examination revealed significant hepatomegaly but the common imagining studies were negative. Following exclusion of common causes of acute hepatitis and because of the presence of smooth muscle antibodies in a young female patient with already established two autoimmune diseases, a liver biopsy was performed in order to exclude the potential presence of autoimmune hepatitis. However, liver histology showed typical findings of GH. Intense treatment targeting strict glycemic control resulted in normalisation of liver biochemistry. This case underlines that GH should be considered as a rare cause of acute hepatitis in T1DM patients with poor glycemic control.

Keywords: diabetes; hepatitis other; metabolic disorders; pathology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
The hepatocytes show clear cytoplasm with distinct cytoplasmic membranes. There is no steatosis. (A) Original magnification H&E 10×; (B) original magnification H&E 40×.
Figure 2
Figure 2
(A) Intense cytoplasmic staining is seen in PAS stain (original magnification 40×). (B) Loss of cytoplasmic staining in PAS diastase stain, consistent with accumulation of glycogen (original magnification 40×). PAS, periodic acid–Schiff stain.

References

    1. Mauriac P. [Hepatomegaly, dwarfism, obesity and diabetes in children: Mauriac’s syndrome]. Vida Nueva 1951;67:57–65. - PubMed
    1. Torbenson M, Chen YY, Brunt E, et al. . Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol 2006;30:508–13. - PubMed
    1. Messeri S, Messerini L, Vizzutti F, et al. . Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damage. Ann Hepatol 2012;11:554–8. - PubMed
    1. Julián MT, Alonso N, Ojanguren I, et al. . Hepatic glycogenosis: an underdiagnosed complication of diabetes mellitus? World J Diabetes 2015;6:321–5. 10.4239/wjd.v6.i2.321 - DOI - PMC - PubMed
    1. Hwang JH, Perseghin G, Rothman DL, et al. . Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study. J Clin Invest 1995;95:783–7. 10.1172/JCI117727 - DOI - PMC - PubMed

Publication types

MeSH terms